Role of Olaparib in the Management of Metastatic Castration-Resistant Prostate Cancer: A Japanese Clinician's Perspective

被引:2
作者
Matsumoto, Takashi [1 ]
Shiota, Masaki [1 ,2 ]
Blas, Leandro [1 ]
Eto, Masatoshi [1 ]
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Urol, Fukuoka, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Dept Urol, 3-1-1 Maidashi,Higashi Ku, Fukuoka 8128582, Japan
关键词
olaparib; metastatic castration-resistant prostate cancer; Japanese; BRCA; companion diagnosis; genomic profile; DNA-REPAIR; DEFECTS; BIOLOGY;
D O I
10.2147/CMAR.S326114
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Several studies have identified various targetable genomic alterations in prostate cancer, which accumulate during carcinogenesis and cancer progression. Genomic alterations in genes involved in DNA damage repair by homologous recombination repair may predict increased sensitivity to poly-ADP ribose polymerase (PARP) inhibitors. The Phase 3 PROfound trial has shown that treatment with the PARP inhibitor olaparib was associated with an improved radiographic progression-free survival and overall survival among patients with homologous recombination repair-deficient metastatic castration-resistant prostate cancer (mCRPC) after the treatment with androgen receptor targeting therapy, especially in men with BRCA1 or BRCA2 mutation. In Japan, olaparib was approved in December 2020 for the treatment of mCRPC with BRCA1 or BRCA2 mutation. In addition, genetic tests to detect BRCA1 or BRCA2 mutation to select patients who are likely to benefit from olaparib were also approved. This review summarizes the status of olaparib treatment for mCRPC, focusing on the situation in Japan.
引用
收藏
页码:2389 / 2397
页数:9
相关论文
共 63 条
[1]   Clonal haematopoiesis: a source of biological noise in cell-free DNA analyses [J].
Abbosh, C. ;
Swanton, C. ;
Birkbak, N. J. .
ANNALS OF ONCOLOGY, 2019, 30 (03) :358-359
[2]   The Molecular Taxonomy of Primary Prostate Cancer [J].
Abeshouse, Adam ;
Ahn, Jaeil ;
Akbani, Rehan ;
Ally, Adrian ;
Amin, Samirkumar ;
Andry, Christopher D. ;
Annala, Matti ;
Aprikian, Armen ;
Armenia, Joshua ;
Arora, Arshi ;
Auman, J. Todd ;
Balasundaram, Miruna ;
Balu, Saianand ;
Barbieri, Christopher E. ;
Bauer, Thomas ;
Benz, Christopher C. ;
Bergeron, Alain ;
Beroukhim, Rameen ;
Berrios, Mario ;
Bivol, Adrian ;
Bodenheimer, Tom ;
Boice, Lori ;
Bootwalla, Moiz S. ;
dos Reis, Rodolfo Borges ;
Boutros, Paul C. ;
Bowen, Jay ;
Bowlby, Reanne ;
Boyd, Jeffrey ;
Bradley, Robert K. ;
Breggia, Anne ;
Brimo, Fadi ;
Bristow, Christopher A. ;
Brooks, Denise ;
Broom, Bradley M. ;
Bryce, Alan H. ;
Bubley, Glenn ;
Burks, Eric ;
Butterfield, Yaron S. N. ;
Button, Michael ;
Canes, David ;
Carlotti, Carlos G. ;
Carlsen, Rebecca ;
Carmel, Michel ;
Carroll, Peter R. ;
Carter, Scott L. ;
Cartun, Richard ;
Carver, Brett S. ;
Chan, June M. ;
Chang, Matthew T. ;
Chen, Yu .
CELL, 2015, 163 (04) :1011-1025
[3]  
Abida W, 2018, ANN ONCOL, V29, DOI [DOI 10.1093/ANNONC/MDY284.002, 10.1093/annonc/mdy284.002]
[4]   Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration [J].
Abida, Wassim ;
Patnaik, Akash ;
Campbell, David ;
Shapiro, Jeremy ;
Bryce, Alan H. ;
McDermott, Ray ;
Sautois, Brieuc ;
Vogelzang, Nicholas J. ;
Bambury, Richard M. ;
Voog, Eric ;
Zhang, Jingsong ;
Piulats, Josep M. ;
Ryan, Charles J. ;
Merseburger, Axel S. ;
Daugaard, Gedske ;
Heidenreich, Axel ;
Fizazi, Karim ;
Higano, Celestia S. ;
Krieger, Laurence E. ;
Sternberg, Cora N. ;
Watkins, Simon P. ;
Despain, Darrin ;
Simmons, Andrew D. ;
Loehr, Andrea ;
Dowson, Melanie ;
Golsorkhi, Tony ;
Chowdhury, Simon .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (32) :3763-+
[5]   Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision Making [J].
Abida, Wassim ;
Armenia, Joshua ;
Gopalan, Anuradha ;
Brennan, Ryan ;
Walsh, Michael ;
Barron, David ;
Danila, Daniel ;
Rathkopf, Dana ;
Morris, Michael ;
Slovin, Susan ;
McLaughlin, Brigit ;
Curtis, Kristen ;
Hyman, David M. ;
Durack, Jeremy C. ;
Solomon, Stephen B. ;
Arcila, Maria E. ;
Zehir, Ahmet ;
Syed, Aijazuddin ;
Gao, Jianjiong ;
Chakravarty, Debyani ;
Vargas, Hebert Alberto ;
Robson, Mark E. ;
Vijai, Joseph ;
Offit, Kenneth ;
Donoghue, Mark T. A. ;
Abeshouse, Adam A. ;
Kundra, Ritika ;
Heins, Zachary J. ;
Penson, Alexander V. ;
Harris, Christopher ;
Taylor, Barry S. ;
Ladanyi, Marc ;
Mandelker, Diana ;
Zhang, Liying ;
Reuter, Victor E. ;
Kantoff, Philip W. ;
Solit, David B. ;
Berger, Michael F. ;
Sawyers, Charles L. ;
Schultz, Nikolaus ;
Scher, Howard I. .
JCO PRECISION ONCOLOGY, 2017, 1 :1-26
[6]  
Agarwal N, J CLIN ONCOL, V40, DOI [10.1200/JCO.2022.40, DOI 10.1200/JCO.2022.40]
[7]   Dairy products, calcium, and prostate cancer risk: a systematic review and meta-analysis of cohort studies [J].
Aune, Dagfinn ;
Rosenblatt, Deborah A. Navarro ;
Chan, Doris S. M. ;
Vieira, Ana Rita ;
Vieira, Rui ;
Greenwood, Darren C. ;
Vatten, Lars J. ;
Norat, Teresa .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2015, 101 (01) :87-117
[8]   Spatial genomic heterogeneity within localized, multifocal prostate cancer [J].
Boutros, Paul C. ;
Fraser, Michael ;
Harding, Nicholas J. ;
de Borja, Richard ;
Trudel, Dominique ;
Lalonde, Emilie ;
Meng, Alice ;
Hennings-Yeomans, Pablo H. ;
McPherson, Andrew ;
Sabelnykova, Veronica Y. ;
Zia, Amin ;
Fox, Natalie S. ;
Livingstone, Julie ;
Shiah, Yu-Jia ;
Wang, Jianxin ;
Beck, Timothy A. ;
Have, Cherry L. ;
Chong, Taryne ;
Sam, Michelle ;
Johns, Jeremy ;
Timms, Lee ;
Buchner, Nicholas ;
Wong, Ada ;
Watson, John D. ;
Simmons, Trent T. ;
P'ng, Christine ;
Zafarana, Gaetano ;
Nguyen, Francis ;
Luo, Xuemei ;
Chu, Kenneth C. ;
Prokopec, Stephenie D. ;
Sykes, Jenna ;
Dal Pra, Alan ;
Berlin, Alejandro ;
Brown, Andrew ;
Chan-Seng-Yue, Michelle A. ;
Yousif, Fouad ;
Denroche, Robert E. ;
Chong, Lauren C. ;
Chen, Gregory M. ;
Jung, Esther ;
Fung, Clement ;
Starmans, Maud H. W. ;
Chen, Hanbo ;
Govind, Shaylan K. ;
Hawley, James ;
D'Costa, Alister ;
Pintilie, Melania ;
Waggott, Daryl ;
Hach, Faraz .
NATURE GENETICS, 2015, 47 (07) :736-+
[9]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]
[10]   Supraphysiological androgens suppress prostate cancer growth through androgen receptor-mediated DNA damage [J].
Chatterjee, Payel ;
Schweizer, Michael T. ;
Lucas, Jared M. ;
Coleman, Ilsa ;
Nyquist, Michael D. ;
Frank, Sander B. ;
Tharakan, Robin ;
Mostaghel, Elahe ;
Luo, Jun ;
Pritchard, Colin C. ;
Lam, Hung-Ming ;
Corey, Eva ;
Antonarakis, Emmanuel S. ;
Denmeade, Samuel R. ;
Nelson, Peter S. .
JOURNAL OF CLINICAL INVESTIGATION, 2019, 129 (10) :4245-4260